Wednesday, 20 June 2018 13:55

Fonterra’s billion-dollar Beingmate bungle?

Written by 
Business commentator Rod Oram is scathing of Fonterra’s performance around Beingmate. Business commentator Rod Oram is scathing of Fonterra’s performance around Beingmate.

Fonterra shareholders could end up losing over $1 billion on the co-op’s controversial investment in Chinese infant formula company Beingmate, says business commentator Rod Oram.

Oram believes it is “incredibly difficult” to turn around Beingmate and Fonterra’s 18.8% stake will “ultimately be valueless”.

He made the comments at a North Asia Centre of Asia-Pacific Excellence event in Auckland; Oram spoke on “Fonterra’s travails in China”. About 50 people, including former Fonterra directors Greg Gent and Colin Armer, attended.

Oram, who has been visiting China as a business journalist since 1979, believes the Beingmate investment, worth $750m in 2015 was a wrong move.

He notes that by 2014 Fonterra was in “deep crisis”. 

It was battling the aftermath of botulism crisis both at home and abroad; Danone, a large infant formula customer had severed ties leaving its Darnum infant formula plant in Victoria seriously underutilised.

Fonterra was also out of the game with its own brand of infant formula in China; desperately needing to build its reputation with Chinese Government and consumers.

The solution was Beingmate, with 10% infant formula market share via a vast network of affiliated retailers. Beingmate was already a Chinese customer for Fonterra ingredients for formulas.

Oram says Beingmate’s owner, Sam Xie, saw an opportunity when Fonterra chief executive Theo Spierings offered to buy the 18.8% stake.

“They knew Fonterra had to find a major partner to make Darnum economically viable again; Fonterra was eager to overcome its market failure in China with its own infant formula brands; and Fonterra believed it had to show the Chinese government it was serious about investing locally despite all its setbacks,” says Oram.

But Beingmate never became the “game-changer” that Spierings had envisaged.

In fact, Beingmate’s problems were beginning to surface as Spierings and Xie finalised their deal.

In March 2015, Beingmate reported that sales fell 17.24% to 5.06 billion yuan, having peaked at 6.11b yuan in 2013; operating profits fell 89% to 104.4m yuan and net profit attributable to shareholders fell 91% to 65.7m yuan from 721m yuan the previous year.

Oram says of the seven strategic objectives Fonterra gave for its Beingmate, only two have borne some fruits; Beingmate is selling Fonterra’s Anmum infant formula but sales have been minimal. Beingmate also took a 51% stake in the Darnum plant but is buying less than its share of the factory output.

“The other five strategic objectives simply have not eventuated, simple as that,” says Oram.

“Beingmate plunged into loss shortly after Fonterra took its stake; it hasn’t paid any dividends to date so Fonterra has lost out on that.”

Fonterra has written down its Beingmate investment from $750m to $244m, a 67% devaluation.

Oram says with $120m in debt costs, $28m in share of losses and $48m in lost dividends, Fonterra is “in the hole” by $702m.

Questions for board

Oram says Fonterra was under pressure to make a big strategic investment in China and Beingmate took advantage of the co-op’s position.

He says it would be interesting to get a copy of the Fonterra board’s due diligence on Beingmate before its investment – given the company “was already on a slide when Fonterra was taking an interest in it”.

Despite Beingmate failing to deliver on the prospects promised, Oram noted that Fonterra’s board and management had “doggedly stuck” with the company.

“It seems Fonterra’s board was hoping for the best, but never prepared for the worst; that question needs to be asked of directors.”

More like this

China keeps dairy prices high

Whole milk powder (WMP) prices are now sitting above pre-Covid-19 levels and New Zealand farmers can thank a resurging Chinese economy for that.

China back on track?

Life in China is starting to get back to some semblance of normality, according to MPI’s deputy director general of China Relations.

A ticking time bomb

Our dairy industry risks being exposed to a ‘ticking time bomb’ of unethical players unlawfully passing off New Zealand-made and packed milk powder products in China as supplements for babies.

MPI says it will act

MPI says it takes the claims made by Jane Li seriously and where it has evidence that exporters are not meeting their requirements, it will take action.

Featured

Water reforms come at a cost

The government’s new freshwater laws, signed off this week, have the potential to create significant unnecessary costs for ratepayers, farmers and entire communities, Federated Farmers says.

2020 harvest yields up

Final harvest data for wheat, barley and oats (milling/malting and feed) in 2020 show yields were up 17% overall across the six crops.

 

Difficult but the right call

DairyNZ chief executive Dr Tim Mackle says the joint decision three years ago to eradicate Mycoplamsa bovis was a difficult call.

Milking cluster milks runner-up award

DeLaval has come away with the runner up prize in this year’s Fieldays Online innovation competition with a new milking cluster that eliminates the need for conventional liner changes.

Glow worms to cows

Thomas Lundman's work focus has gone from tracking tiny critters in pitch black caves to looking after considerably larger animals in paddocks near Whakatane.

» Latest Print Issues Online

The Hound

Spell check

Your old mutt was not surprised to see the NZ Dairy Industry Awards hastily remove the title of this year’s…

About time!

Your canine crusader has been a long-time critic of NZ governments – of all stripes – who, for the past…

» Connect with Rural News

» eNewsletter

Subscribe to our weekly newsletter